Healthcare · Active clinical trials

Active clinical trials in Indonesia in 2026

Indonesia, the world's fourth most populous country, reported zero active clinical trials (250 units) in 2026, ranking 16 out of 197. This is not due to a lack of need — on the contrary, its vast population with diverse genetic and epidemiological profiles could be an ideal research setting. However, a weak regulatory framework, a shortage of skilled professionals, and limited funding have held the sector back. In recent years, Indonesia has begun attracting international pharmaceutical companies by streamlining approval processes.

Data for 2026 · unit: units
Position

Indonesia world ranking

#16 / 197

Country position on the scale from last to first place for this indicator.

ID
#16
#197#1
Trend

Change over time

Change in indicator over the available period.

2
1990
10
2000
50
2010
200
2020
100
2025
250
2026

Values — units

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Active clinical trials in Indonesia — how much?
Based on 2026 data — 250 units. This is rank #16 out of 197 countries.
What is Indonesia's rank by Active clinical trials?
Indonesia ranks #16 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Indonesia?
Over the available period the indicator changed from 2 to 250 units.